JAMA 2022

• INFO Patient : âge et permis de conduire
  Conduire peut être dangereux
• JAMA Hit Parade des articles 2022 CANCER
  
  "Il n'y a pas de classement de l'univers qui ne soit arbitraire et conjectural. La raison en est très simple : nous ne savons pas quelle chose est l'univers.”  Jorge Luis Borges / Otras Inquisiciones
   
  Classement qui repose sur les scores ALTMETRIC
  
  
  
  
  

  The Most Talked About Articles of 2022

  These are the most discussed articles published in JAMA Oncology in 2022 as measured by Altmetric, which provides a quantitative measure of the attention each scholarly article receives in traditional and social media. Click the article links to read the articles or the badge numbers to learn more about the article's Altmetric performance.*

  1495 Trends in Cancer Mortality Among Black Individuals in the US From 1999 to 2019 1140 Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype 1065 Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma 978 Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 597 Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases 563 Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic 538 Association of Daily Sitting Time and Leisure-Time Physical Activity With Survival Among US Cancer Survivors 535 Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis 495 Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity 493 Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women

  * Altmetric scores from December 2022; numbers may change with time.